Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Chemistry and Biology

• Publication date

  2013-09-19

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.chembiol.2013.08.004PMID 24035283PMCID PMC3815696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hsp90, an unlikely ally in the war on cancer

  2013cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Associating retinal drug exposure and retention with the ocular toxicity profiles of Hsp90 inhibitors.

  2012cited by this paper
• A highly selective Hsp90 affinity chromatography resin with a cleavable linker.

  2012cited by this paper
• Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

  2012cited by this paper
• Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer

  2012cited by this paper
• Post-translational modifications of Hsp90 and their contributions to chaperone regulation.

  2012cited by this paper
• Experimental validation of an inverse fluorescence Monte Carlo model to extract concentrations of metabolically relevant fluorophores from turbid phantoms and a murine tumor model.

  2012cited by this paper
• The expanding proteome of the molecular chaperone HSP90

  2012cited by this paper
• Utility of 18FDG-PET/CT in breast cancer diagnostics--a systematic review.

  2011cited by this paper
• Extracellular Heat Shock Protein (Hsp)70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion

  2011cited by this paper
• An Interaction Network Predicted from Public Data as a Discovery Tool: Application to the Hsp90 Molecular Chaperone Machine

  2011cited by this paper
• The 4C5 Cell-Impermeable Anti-HSP90 Antibody with Anti-Cancer Activity, Is Composed of a Single Light Chain Dimer

  2011cited by this paper
• Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation

  2010cited by this paper
• Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits

  2010cited by this paper
• Targeting the dynamic HSP90 complex in cancer

  2010cited by this paper
• STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer.

  2010cited by this paper
• Understanding of the Hsp90 molecular chaperone reaches new heights

  2010cited by this paper
• Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90.

  2010cited by this paper
• Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening

  2010cited by this paper
• Non-invasive monitoring of intra-tumor drug concentration and therapeutic response using optical spectroscopy.

  2010cited by this paper
• The complex dance of the molecular chaperone Hsp90.

  2009cited by this paper
• Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo.

  2009cited by this paper
• BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy

  2009cited by this paper
• The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy

  2009cited by this paper
• Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.

  2009cited by this paper
• Rethinking screening for breast cancer and prostate cancer.

  2009cited by this paper
• Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain

  2009cited by this paper
• Update on Hsp90 inhibitors in clinical trial.

  2009cited by this paper
• Monte-Carlo-based model for the extraction of intrinsic fluorescence from turbid media.

  2008cited by this paper
• A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion

  2008cited by this paper
• Extracellular heat shock protein 90: A role for a molecular chaperone in cell motility and cancer metastasis

  2007cited by this paper
• Screening for cancer with PET and PET/CT: potential and limitations.

  2007cited by this paper
• High HSP90 expression is associated with decreased survival in breast cancer.

  2007cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• HSP90 and the chaperoning of cancer

  2005cited by this paper
• Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex

  2005cited by this paper
• Is whole-body FDG-PET valuable for health screening?

  2005cited by this paper
• Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness

  2004cited by this paper
• Phosphoproteome analysis in yeast.

  2003cited by this paper
• A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

  2003cited by this paper
• Development of purine-scaffold small molecule inhibitors of Hsp90.

  2003cited by this paper
• Associate Editor: D. Shugar The 90-kDa Molecular Chaperone Family: Structure, Function, and Clinical Applications. A Comprehensive Review

  1998cited by this paper
• The Amino-terminal Domain of Heat Shock Protein 90 (hsp90) That Binds Geldanamycin Is an ATP/ADP Switch Domain That Regulates hsp90 Conformation*

  1997cited by this paper
• Transforming Growth Factor (cid:2) (TGF (cid:2) )-Stimulated Secretion of HSP90 (cid:2) : Using the Receptor LRP-1/CD91 To Promote Human Skin Cell Migration against a TGF (cid:3) -Rich Environment during Wound Healing (cid:1) †

  year unknowncited by this paper

• Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth

  2026influential citation
• Long-circulating enzyme-activated HSP90-targeted camptothecin derivatives.

  2025cites this paper
• [11C]HSP990 PET as a translational tool to investigate the role of Hsp90 in tumours and support the development of Hsp90 therapeutics

  2025cites this paper
• Development and evaluation of Hsp90-targeting nanobodies for visualisation of extracellular Hsp90 in tumours using PET imaging

  2025cites this paper
• In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration

  2025cites this paper
• Engineered Proteins and Chemical Tools to Probe the Cell Surface Proteome

  2025cites this paper
• In vivo imaging of heat shock protein 90: Diagnostic tool and support for Hsp90-targeted therapy

  2025cites this paper
• Extracellular heat shock protein 90 alpha (eHsp90α)'s role in cancer progression and the development of therapeutic strategies.

  2024cites this paper
• The Role of eHsp90 in Extracellular Matrix Remodeling, Tumor Invasiveness, and Metastasis

  2024cites this paper
• Rationally modified SNX-class Hsp90 inhibitors disrupt extracellular fibronectin assembly without intracellular Hsp90 activity

  2024cites this paper
• Hsp90 inhibition leads to an increase in surface expression of multiple immunological receptors in cancer cells

  2024cites this paper
• Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development.

  2023cites this paper
• Extracellular Hsp90 Binds to and Aligns Collagen-1 to Enhance Breast Cancer Cell Invasiveness

  2023cites this paper
• Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer.

  2023cites this paper
• Design, Synthesis, and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (Hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant Prostate Cancer.

  2023cites this paper
• Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice

  2023cites this paper
• Expression of membrane Hsp90 is a molecular signature of T cell activation

  2022cites this paper
• A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity

  2022cites this paper
• The advantages and disadvantages of novel contrast agent types for fluorescence guided surgery

  2022cites this paper
• HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study

  2021cites this paper
• Current trends and key considerations in the clinical translation of targeted fluorescent probes for intraoperative navigation

  2021cites this paper
• Understanding the sources of errors in ex vivo Hsp90 molecular imaging for rapid-on-site breast cancer diagnosis.

  2021cites this paper
• Expression of ectopic heat shock protein 90 in male and female primary afferent nociceptors regulates inflammatory pain.

  2021cites this paper
• Expression of extracellular Hsp90 is a molecular signature of T cell activation, providing a means to image and target T Cell activation in autoimmune disease

  2021cites this paper
• Leveraging Surface Hsp90 Expression for Rapid-on-site Breast Cancer Diagnostics

  2020cites this paper
• Design, synthesis and biological evaluation of HSP90 inhibitor-SN38 conjugates for targeted drug accumulation.

  2020cites this paper
• Fluorescence image-guided surgery: a perspective on contrast agent development

  2020cites this paper
• Optimized HSP90 mediated fluorescent probes for cancer-specific bioimaging.

  2020cites this paper
• Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors

  2020cites this paper
• Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors

  2020cites this paper
• Role of HSP90 Inhibitors in the Treatment of Cancer

  2019cites this paper
• Evaluation of [11C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90

  2019cites this paper
• Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer

  2019cites this paper
• Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications

  2018cites this paper
• Optimizing fluorescently tethered Hsp90 inhibitor dose for maximal specific uptake by breast tumors

  2018cites this paper
• A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.

  2018cites this paper
• In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior

  2017cites this paper
• Radiotherapy plus Heat Shock Protein 90 Inhibition: Sensitizing Cancer Cells to Irradiation-Induced Cell Death and Enhancing their Immunogenicity

  2017cites this paper
• Targeting Transforming Growth Factor Beta-Activated Kinase 1 as a Therapeutic Strategy in Cancer and Immune Disease

  2017cites this paper
• AWARD NUMBER: W81XWH-15-1-0072 TITLE: Development of Tethered Hsp90 Inhibitors Carrying Radioiodinated Probes to Specifically Discriminate and Kill Malignant Breast Tumor Cells

  2017cites this paper
• Molecular and functional crosstalk between extracellular Hsp90 and ephrin A1 signaling

  2017cites this paper
• A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo.

  2017cites this paper
• Molecular and functional crosstalk between extracellular Hsp 90 and ephrin A 1 signaling

  2017cites this paper
• Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.

  2017cites this paper
• Leveraging ectopic Hsp90 expression to assay the presence of tumor cells and aggressive tumor phenotypes in breast specimens

  2017cites this paper
• Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity

  2017cites this paper
• Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.

  2017cites this paper
• Tumor suppressor Tsc1 is a new Hsp90 co‐chaperone that facilitates folding of kinase and non‐kinase clients

  2017cites this paper
• Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease.

  2016cites this paper
• Hsp90 Inhibitors in Parasitic Nematodes: Prospects and Challenges.

  2016cites this paper
• The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding

  2016cites this paper
• A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer

  2016cites this paper
• Emerging Roles of Extracellular Hsp90 in Cancer.

  2016cites this paper
• Secreted heat shock protein 90 promotes prostate cancer stem cell heterogeneity

  2016cites this paper
• Development of Tethered Hsp90 Inhibitors Carrying Radioiodinated Probes to Specifically Discriminate and Kill Malignant Breast Tumor Cells

  2016cites this paper
• Novel Hsp 90 Inhibitor , Exhibits Diagnostic and Therapeutic Potential in Triple Negative Breast Cancer

  2016cites this paper
• An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.

  2016cites this paper
• Hsp 90 Inhibitors in Parasitic Nematodes : Prospects and Challenges Running title : Hsp 90 in parasitic nematodes

  2016cites this paper
• HSP90 Inhibitor–SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors

  2015cites this paper
• Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity.

  2015cites this paper
• Targeting Inducible Heat Shock Protein 70 in Cancer and Dengue Virus Pathogenesis with a Novel Small Molecule Inhibitor

  2015cites this paper
• Peptide-Based Probe Specific Hsp 70 − Xenograft Tumors Using a Novel Tumor Cell Imaging of Syngeneic , Spontaneous , and In Vivo Selective

  2014cites this paper
• Hsp 70 peptide-based probe Selective in vivo imaging of tumors with a tumor cell-specific

  2014cites this paper
• An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like Protein

  2014cites this paper
• Selective in vivo imaging of syngeneic, spontaneous and xenograft tumors using a novel tumor cell-specific Hsp70 peptide-based probe

  2014cites this paper
• Selective in vivo imaging of syngeneic, spontaneous, and xenograft tumors using a novel tumor cell-specific hsp70 peptide-based probe.

  2014cites this paper
• Targeting Ectopic Hsp90 in Breast Cancer

  2014cites this paper